微生物与感染
2025年1月9日 星期四   首页 |  主编心语 |  期刊介绍 |  编委阵容 |  投稿指南 |  出版道德 |  期刊订阅 |  联系我们 | English
微生物与感染  2017, Vol. 12 Issue (6): 362-368    
  综述 本期目录 | 过刊浏览 | 高级检索 |
耐药结核分枝杆菌的适应性代价与补偿性进化
皮锐,柳清云,高谦
复旦大学基础医学院,医学分子病毒学教育部/卫生部重点实验室,上海 200032
Fitness cost and compensatory evolution of drug-resistant Mycobacterium tuberculosis
PI Rui, LIU Qingyun, GAO Qian
Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China
全文: PDF (598 KB)   HTML (0)
输出: BibTeX | EndNote (RIS)      
摘要: 结核病耐药率的攀升是目前全球结核病防控面临的重大挑战。结核分枝杆菌主要通过其基因组中耐药相关基因发生点突变而获得耐药性。由于耐药相关基因通常具有重要的生理功能,其突变往往会导致结核分枝杆菌自身适应性下降,即产生“适应性代价”。然而,耐药结核分枝杆菌可通过进一步积累其他特定突变来回复其适应性,这种能使其适应性上升的突变称为“补偿性突变”。耐药结核分枝杆菌的补偿性进化被认为是耐药结核病广泛传播与流行的生物学基础。近年来,在结核病分子流行病学和基础研究领域,针对耐药结核分枝杆菌的补偿性进化开展了大量研究。本文从结核分枝杆菌的耐药分子机制、耐药突变的适应性代价与补偿性进化,以及补偿性进化如何影响耐药结核病传播等方面,综述耐药结核分枝杆菌补偿性进化的研究进展。

服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
皮锐
柳清云
高谦
关键词 结核分枝杆菌耐药突变适应性代价补偿性进化异位显性    
Abstract:The increasing rate of drug resistance in tuberculosis possesses a great challenge to the global tuberculosis control. The drug resistance in Mycobacterium tuberculosis (M. tuberculosis) is mainly conferred by chromosomal mutations in essential and highly conserved genes, and usually accompanied by a reduction in fitness, namely “fitness cost”. However, this fitness cost can be ameliorated by secondary compensatory mutations which help restore the fitness of drug-resistant strains. The compensatory evolution has been regarded as the biological basis of the extensive spread and high prevalence of drug-resistant M. tuberculosis. Recently, a series of scientific works in the field of molecular epidemiology of tuberculosis and the basic research on the compensatory evolution of drug-resistant M. tuberculosis have been conducted. In this review, we focus on the molecular mechanisms for fitness cost of drug resistance, the compensatory evolution and the potential impacts of these two processes on the transmission of M. tuberculosis.

Key wordsMycobacterium tuberculosis    Drug-resistance mutation    Fitness cost    Compensatory evolution    Epistasis
基金资助:国家自然科学基金(91631301)

通讯作者: 高谦   
引用本文:   
皮锐,柳清云,高谦. 耐药结核分枝杆菌的适应性代价与补偿性进化[J]. 微生物与感染, 2017, 12(6): 362-368.
PI Rui, LIU Qingyun, GAO Qian. Fitness cost and compensatory evolution of drug-resistant Mycobacterium tuberculosis. JOURNAL OF MICROBES AND INFECTIONS, 2017, 12(6): 362-368.
链接本文:  
http://jmi.fudan.edu.cn/CN/     或     http://jmi.fudan.edu.cn/CN/Y2017/V12/I6/362

版权所有 © 2008 《微生物与感染》编辑部
地址:上海市医学院路138号 邮编:200032
Tel:021-54237633 Fax:021-64434224    E-mail:jmi@fudan.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发  技术支持:support@magtech.com.cn